Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine and Estramustine +/- Prednisone in Renal Cell Carcinoma
NCT00003584Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Jul 1998
- Primary completion
- Dec 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine and estramustine in renal cell carcinoma (RCC), sponsored by The University of New Mexico. Primary endpoint: Objective Response Rate. Started Jul 1998; status: completed.
02
Drugs
vinorelbineestramustine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003584.